{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:30:39Z","timestamp":1744173039822,"version":"3.40.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11845-023-03284-y","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T15:02:55Z","timestamp":1675695775000},"page":"2323-2329","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Holistic assessment of patients with chronic mental disorders who attend a metabolic clinic in Sligo Town catchment area"],"prefix":"10.1007","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4954-1249","authenticated-orcid":false,"given":"Memoona","family":"Usman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Adamis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,6]]},"reference":[{"key":"3284_CR1","doi-asserted-by":"crossref","unstructured":"De Hert M, Correll CU, Bobes J et al (2011) Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 10(1):52","DOI":"10.1002\/j.2051-5545.2011.tb00014.x"},{"key":"3284_CR2","unstructured":"Cunningham C, Riano NS, Mangurian C (2018) Screening for metabolic syndrome in people with severe mental illness. J Clin Outcomes Manag 25(1)"},{"issue":"2","key":"3284_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.9740\/mhc.2018.03.049","volume":"8","author":"A Pe\u00f1a","year":"2018","unstructured":"Pe\u00f1a A, DeJongh B, Haas M et al (2018) Overcoming barriers to monitoring patients taking second-generation antipsychotics. Ment Health Clin 8(2):49\u201355","journal-title":"Ment Health Clin"},{"issue":"1","key":"3284_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/wps.20826","volume":"20","author":"M De Hert","year":"2021","unstructured":"De Hert M, Mazereel V, Detraux J et al (2021) Prioritizing COVID-19 vaccination for people with severe mental illness. World Psychiatry 20(1):54","journal-title":"World Psychiatry"},{"issue":"6","key":"3284_CR5","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ahj.2005.02.007","volume":"150","author":"CH Hennekens","year":"2005","unstructured":"Hennekens CH, Hennekens AR, Hollar D et al (2005) Schizophrenia and increased risks of cardiovascular disease. Am Heart J 150(6):1115\u20131121","journal-title":"Am Heart J"},{"issue":"6","key":"3284_CR6","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1177\/0269881109102788","volume":"24","author":"RIG Holt","year":"2010","unstructured":"Holt RIG, Abdelrahman T, Hirsch M et al (2010) The prevalence of undiagnosed metabolic abnormalities in people with serious mental illness. J Psychopharmacol 24(6):867\u2013873","journal-title":"J Psychopharmacol"},{"issue":"2","key":"3284_CR7","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/schbul\/sbr148","volume":"39","author":"AJ Mitchell","year":"2013","unstructured":"Mitchell AJ, Vancampfort D, Sweers K et al (2013) Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders\u2014a systematic review and meta-analysis. Schizophr Bull 39(2):306\u2013318","journal-title":"Schizophrenia Bulletin"},{"key":"3284_CR8","doi-asserted-by":"publisher","unstructured":"American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https:\/\/doi.org\/10.1176\/appi.books.9780890425787","DOI":"10.1176\/appi.books.9780890425787"},{"key":"3284_CR9","doi-asserted-by":"crossref","unstructured":"Waln O, Jankovic J (2013) An update on tardive dyskinesia: from phenomenology to treatment. Tremor Other Hyperkinet Mov 3","DOI":"10.5334\/tohm.165"},{"issue":"1","key":"3284_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1600-0447.1964.tb05731.x","volume":"40","author":"A Faurbye","year":"1964","unstructured":"Faurbye A, Rasch PJ, Petersen PB et al (1964) Neurological symptoms in pharmagotherapy of psychoses. Acta Psychiatr Scand 40(1):10\u201327","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"3284_CR11","first-page":"162","volume":"17","author":"EM Cornett","year":"2017","unstructured":"Cornett EM, Novitch M, Kaye AD et al (2017) Medication-induced tardive dyskinesia: a review and update. Ochsner Journal 17(2):162\u2013174","journal-title":"Ochsner Journal"},{"issue":"3","key":"3284_CR12","doi-asserted-by":"publisher","first-page":"20738","DOI":"10.4088\/JCP.16r10832","volume":"78","author":"M Carbon","year":"2017","unstructured":"Carbon M, Hsieh CH, Kane JM et al (2017) Tardive dyskinesia prevalence in the period of second-generation antipsychotic use: a meta-analysis. J Clin Psychiatry 78(3):20738","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"3284_CR13","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1007\/s11136-019-02269-8","volume":"28","author":"J McEvoy","year":"2019","unstructured":"McEvoy J, Gandhi SK, Rizio AA et al (2019) Effect of tardive dyskinesia on quality of life in patients with bipolar disorder, major depressive disorder, and schizophrenia. Qual Life Res 28(12):3303\u20133312","journal-title":"Qual Life Res"},{"key":"3284_CR14","doi-asserted-by":"publisher","unstructured":"Usman M, Saleem F, McCafferty B et al (2022) Establishing a dedicated metabolic clinic for patients with chronic mental illness. Ir J Psychol Med 1\u20132. Advance online publication. https:\/\/doi.org\/10.1017\/ipm.2022.18","DOI":"10.1017\/ipm.2022.18"},{"issue":"S1","key":"3284_CR15","doi-asserted-by":"publisher","first-page":"S564","DOI":"10.1016\/j.eurpsy.2016.01.2089","volume":"33","author":"M Gill","year":"2016","unstructured":"Gill M, McCauley M (2016) Establishing a physical health monitoring service for patients on depot antipsychotic medication. Eur Psychiatry 33(S1):S564\u2013S564","journal-title":"Eur Psychiatry"},{"issue":"2","key":"3284_CR16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/1078390320906196","volume":"27","author":"KT Bomboy","year":"2021","unstructured":"Bomboy KT, Graber JS, Wallis EP (2021) Improved prescriber adherence to guidelines on antipsychotic medication management through increased access to metabolic monitoring forms. J Am Psychiatr Nurses Assoc 27(2):162\u2013168","journal-title":"J Am Psychiatr Nurses Assoc"},{"issue":"2","key":"3284_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1067\/mpn.2002.124918","volume":"8","author":"V Menzies","year":"2002","unstructured":"Menzies V, Farrell SP (2002) Schizophrenia, tardive dyskinesia, and the abnormal involuntary movement scale (AIMS). J Am Psychiatr Nurses Assoc 8(2):51\u201356","journal-title":"J Am Psychiatr Nurses Assoc"},{"issue":"1","key":"3284_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1192\/bjp.172.1.11","volume":"172","author":"JK Wing","year":"1998","unstructured":"Wing JK, Beevor AS, Curtis RH et al (1998) Health of the Nation Outcome Scales (HoNOS): research and development. Br J Psychiatry 172(1):11\u201318","journal-title":"Br J Psychiatry"},{"issue":"3","key":"3284_CR19","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1017\/S0033291798006667","volume":"28","author":"Whoqol Group","year":"1998","unstructured":"Whoqol Group (1998) Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 28(3):551\u2013558","journal-title":"Psychol Med"},{"issue":"1","key":"3284_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-020-02990-6","volume":"20","author":"RA Ali","year":"2020","unstructured":"Ali RA, Jalal Z, Paudyal V (2020) Barriers to monitoring and management of cardiovascular and metabolic health of patients prescribed antipsychotic drugs: a systematic review. BMC Psychiatry 20(1):1\u201315","journal-title":"BMC Psychiatry"},{"issue":"9896","key":"3284_CR21","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","volume":"382","author":"S Leucht","year":"2013","unstructured":"Leucht S, Cipriani A, Spineli L et al (2013) Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 382(9896):951\u2013962","journal-title":"Lancet"},{"key":"3284_CR22","first-page":"99","volume":"12","author":"A de Bartolomeis","year":"2016","unstructured":"de Bartolomeis A, Fagiolini A, Vaggi M et al (2016) Targets, attitudes, and goals of psychiatrists treating patients with schizophrenia: key outcome drivers, role of quality of life, and place of long-acting antipsychotics. Neuropsychiatr Dis Treat 12:99","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"3284_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7525-10-138","volume":"10","author":"J Connell","year":"2012","unstructured":"Connell J, Brazier J, O\u2019Cathain A et al (2012) Quality of life of people with mental health problems: a synthesis of qualitative research. Health Qual Life Outcomes 10(1):1\u201316","journal-title":"Health Qual Life Outcomes"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-023-03284-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-023-03284-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-023-03284-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:34:34Z","timestamp":1744158874000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-023-03284-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,6]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["3284"],"URL":"https:\/\/doi.org\/10.1007\/s11845-023-03284-y","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"type":"print","value":"0021-1265"},{"type":"electronic","value":"1863-4362"}],"subject":[],"published":{"date-parts":[[2023,2,6]]},"assertion":[{"value":"26 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committee on human experimentation with the Helsinki declaration of 1975 as revised in 2008. The authors assert that ethical approval for this research was granted by the local ethics committee. Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}